These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9627738)
41. Effects of vitamin E on the endothelium: equivocal? Alpha-tocopherol and endothelial dysfunction. Visioli F Cardiovasc Res; 2001 Aug; 51(2):198-201. PubMed ID: 11470458 [No Abstract] [Full Text] [Related]
42. Essential fatty acid supplementation in tardive dyskinesia. Wolkin A; Jordan B; Peselow E; Rubinstein M; Rotrosen J Am J Psychiatry; 1986 Jul; 143(7):912-4. PubMed ID: 3013033 [TBL] [Abstract][Full Text] [Related]
44. To "E" or not to "E," vitamin E's role in health and disease is the question. Friedrich MJ JAMA; 2004 Aug; 292(6):671-3. PubMed ID: 15304447 [No Abstract] [Full Text] [Related]
45. Partial reversal of the iminodipropionitrile-induced hyperkinetic syndrome in rats by alpha-tocopherol (vitamin E). Lohr JB; Cadet JL; Wyatt RJ; Freed WJ Neuropsychopharmacology; 1988 Dec; 1(4):305-9. PubMed ID: 3251508 [TBL] [Abstract][Full Text] [Related]
46. B vitamins attenuate haloperidol-induced orofacial dyskinesia in rats: possible involvement of antioxidant mechanisms. Macêdo DS; Oliveira GV; Gomes PX; Araújo FY; Souza CM; Vasconcelos SM; Viana GS; Sousa FC; Carvalho AF Behav Pharmacol; 2011 Oct; 22(7):674-80. PubMed ID: 21918383 [TBL] [Abstract][Full Text] [Related]
47. From food constituent to dietary supplement and drug. Is there a role for antioxidants in treatment strategies? Winklhofer-Roob BM Wien Klin Wochenschr; 2000 Jul; 112(14):607-9. PubMed ID: 11008321 [No Abstract] [Full Text] [Related]
48. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction. Naidu PS; Singh A; Kulkarni SK Phytother Res; 2006 Feb; 20(2):140-6. PubMed ID: 16444668 [TBL] [Abstract][Full Text] [Related]
49. Double-blind study of lecithin in the treatment of persistent tardive dyskinesia. Pérez-Cruet J; Menéndez I; Alvarez-Ghersi J; Falcón JR; Valderrábano O; Castro-Urrutia EC; Ifarraguerri C; Pérez LL Bol Asoc Med P R; 1981 Nov; 73(11):531-7. PubMed ID: 6121562 [No Abstract] [Full Text] [Related]
50. Drug therapy of tardive dyskinesia. Kobayashi RM N Engl J Med; 1977 Feb; 296(5):257-60. PubMed ID: 12469 [No Abstract] [Full Text] [Related]
51. Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia. An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Kosten TR; Zhou DF; Yang FD; Zhang XY Behav Pharmacol; 2013 Oct; 24(7):610-6. PubMed ID: 23994817 [TBL] [Abstract][Full Text] [Related]
58. In search of treatment for tardive dyskinesia: review of the literature. Jeste DV; Wyatt RJ Schizophr Bull; 1979; 5(2):251-93. PubMed ID: 37597 [TBL] [Abstract][Full Text] [Related]
59. Vitamin B(6) in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study. Lerner V; Miodownik C; Kaptsan A; Cohen H; Matar M; Loewenthal U; Kotler M Am J Psychiatry; 2001 Sep; 158(9):1511-4. PubMed ID: 11532741 [TBL] [Abstract][Full Text] [Related]